CRMD: Nilai perusahaan marang bathi resik CorMedix Inc

Combating catheter-related infections through partnerships with nephrologists defines the development vector for CorMedix Inc. (CRMD). The price-to-earnings trend visualizes the market valuation of this process, where 5.80 shows the value of this parameter. The effective product launch under competent management is complemented by strict adherence to environmental standards for biohazardous waste disposal, which stabilizes the asset's investment attractiveness.

Rasio rega marang bathi CorMedix Inc (CRMD): kanggo periode 04.07.2022 - 15.11.2026

Rincian metrik komprehensif lan analitis CorMedix Inc (CRMD)

- rega lan prakiraan konsensus rega:

Rega saham CorMedix Corp|CRMD - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar CorMedix Inc|CRMD - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Saham CorMedix|CRMD - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku cormedix.com|CRMD - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang Agregat marang Ekuitas CorMedix Inc.|CRMD - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal CorMedix Inc.|CRMD - Gunggung utang perusahaan|Utang marang nilai buku CorMedix Therapeutics|CRMD - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak CorMedix|Koefisien jangkoan perantara cormedix.com

- rincian bathi lan kelipatan pasar:

CRMD - Bathi resik perusahaan|Bathi resik sing dikarepake CorMedix Inc.|CRMD - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep CorMedix Therapeutics|CRMD - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan CorMedix Inc|CRMD - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan CorMedix|CRMD - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan cormedix.com|CRMD - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep CorMedix Inc.

- indikator volume dodolan lan pendapatan:

CRMD - Pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan CorMedix|CRMD - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CorMedix Inc

Ringkesan analisis perusahaan:CRMD CorMedix Corp

CorMedix Inc. (CRMD) maintains a critical dependence on a single antibacterial drug, rendering the business's market value sensitive to the pace of its clinical adoption. While the relationship between the current price and net income, reflected in the company's historical average P/E, determines the investment payback period, ignoring the debt load when analyzing this metric may lead to an erroneous assessment of capital stability.

Perusahaan pesaing